The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …

Asthma is the most common noncommunicable disease in children, and among the most
common in adults. The great majority of people with asthma live in low and middle income …

Background In patients with mild asthma, as-needed use of an inhaled glucocorticoid plus a
fast-acting β2-agonist may be an alternative to conventional treatment strategies. Methods …

GINA no longer recommends treating adults/adolescents with asthma with short-acting
bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a …

Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and
annually updated a global strategy for asthma management and prevention that has formed …

Artificial intelligence (AI) and machine learning, a subset of AI, are increasingly used in
medicine. AI excels at performing well-defined tasks, such as image recognition; for …

Background: The fractional exhaled nitric oxide (FeNO) test is a point-of-care test that is
used in the assessment of asthma. Objective: To provide evidence-based clinical guidance …

Asthma is a common chronic disease characterized by episodic or persistent respiratory
symptoms and airflow limitation. Asthma treatment is based on a stepwise and control-based …

Inhaled corticosteroids (ICS) are the cornerstone of maintenance asthma therapy. However,
in spite of this, adherence to ICS remains low. The aim of this systematic literature review …

Background Low-dose inhaled corticosteroids (ICS) are highly effective for reducing asthma
exacerbations and mortality. Conventionally, ICS treatment is recommended for patients with …